Form 8-K - Current report:
SEC Accession No. 0001193125-20-136972
Filing Date
2020-05-08
Accepted
2020-05-08 07:43:09
Documents
12
Period of Report
2020-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d927910d8k.htm   iXBRL 8-K 57204
  Complete submission text file 0001193125-20-136972.txt   177800

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrx-20200505.xsd EX-101.SCH 3062
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrx-20200505_lab.xml EX-101.LAB 17372
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrx-20200505_pre.xml EX-101.PRE 10947
7 EXTRACTED XBRL INSTANCE DOCUMENT d927910d8k_htm.xml XML 3245
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 20858692
SIC: 2834 Pharmaceutical Preparations